Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jan 18, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating whether a device called BeatMove can help patients with a type of leg artery disease known as obliterative arterial disease. This condition can cause pain in the legs when walking, which is referred to as claudication. The researchers want to see if using this device, combined with music therapy, can improve patients' ability to walk and enhance their overall health. The trial is currently looking for participants who are between 65 and 74 years old, have been diagnosed with this specific stage of arterial disease, and are receiving appropriate medical treatment.

Eligible participants will need to be able to read and understand French and have given their consent to join the trial. They should not use walking aids like canes or wheelchairs, nor should they have had recent major surgeries or other serious health issues. Those who join can expect to engage in rehabilitation activities that include using the BeatMove device and participating in music therapy, which is believed to help with movement and emotional well-being. This study aims not only to improve walking ability but also to make rehabilitation more accessible for patients who may struggle with traditional programs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with stage II arterial obliteration of the lower limbs (Leriche and Fontaine classification) with exertional claudication
• • Systolic Pressure Index at the toe \< 0.7 but absolute value \> 30 mmHg
• • Steno-occlusive lesions on arterial Doppler ultrasound examination of the lower limbs
• • Patient on an optimised vasculoprotective medical treatment (statin, antiplatelet agent, ACE inhibitor/ARB II)
• • Patient who is a beneficiary or entitled beneficiary of a health insurance scheme
• • Patient able to understand, write and read French
• • Patient who has given free and informed consent
• Exclusion Criteria:
• • Patients using walking aids (cane, wheelchair)
• • Amputation
• • Patient with a walking perimeter \< 150 m
• • Hearing or visual impairment
• • Chronic ischaemia
• • Trophic disorders
• • Orthopaedic or vascular MI surgery planned within 3 months
• • Major cardiovascular co-morbidities (MI \< 3 months or unstable angina)
• • Pregnant, breast-feeding or parturient women
• • Patients under court protection, guardianship or curatorship.